INFORMAZIONI SU QUESTO EPISODIO
In January 2020, Stephen Hahn, M.D., had been running the FDA for just a few weeks when the COVID-19 virus sequence was published. Despite the odds, in just eleven months, the first mRNA vaccine was authorized. It was the fastest development of its kind in history. And the part Hahn can't stop thinking about isn't how hard it was. It's what it proved: medicine can move that fast, even though it usually doesn't.
Now, as Chief Executive Officer of Nucleus RadioPharma, he makes a new argument for data science leaders: the hard part in medicine isn’t the science. It’s what we do with the data.
Stephen brings:
- Why he calls AI in molecule discovery “table stakes”
- What leading the largest real-world experiment in history taught him
- How the FDA compressed years into months, and how we can do it again
Inglese
Stati Uniti
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di Data Science Leaders.
ALTRI EPISODI IN QUESTO PODCAST
AI is transforming financial services and insurance, but rarely in the headline-grabbing ways you might expect. From intelligent process automation to fraud detection and risk management, AI is being embedded across operations, but as AI adoption grows, so do the challenges—cybercrime, rapid techno…
What does the near term future of Enterprise AI look like? A scramble to get valuable, cost-effective, enterprise-grade AI solutions into production, with rigorous governance at scale. If that sounds like a tall order - that’s because it is! However, large advanced organizations (yes, even outside …
What’s next for artificial intelligence in 2025? In this episode, Dr. Kjell Carlsson delivers his annual predictions about the immediate future of AI. From AI becoming the universal corporate scapegoat to the rebranding of generative AI as "agentic AI.” Discover why commercial AI solutions remain s…
AI is transforming drug discovery and clinical trials, making what was once cutting-edge the new standard. Pharma companies are evolving into tech companies, leveraging AI to revolutionize every phase of drug development.In this episode, Chris McSpiritt, VP of Life Sciences Strategy at Domino, disc…
What does the global race for AI look like? How has the US Department of Defense been adopting AI by engaging the private sector? And how should we expect AI policy to shift under the new administration?
In this episode – the last in our series on the future of AI – guest host Joel Meye…
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Domino Data Lab, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
